Effects of Bardoxolone Methyl in Alport Syndrome

Warady, B. A., Pergola, P. E., Agarwal, R., Andreoli, S., Appel, G. B., Bangalore, S., Block, G. A., Chapman, A. B., Chin, M. P., Gibson, K. L., Goldsberry, A., Iijima, K., Inker, L. A., Kashtan, C. E., Knebelmann, B., Mariani, L. H., Meyer, C. J., Nozu, K., O’Grady, M., … Chertow, G. M. (2022). Effects of Bardoxolone Methyl in Alport Syndrome. Clinical Journal of the American Society of Nephrology, 17(12), 1763–1774. https://doi.org/10.2215/cjn.02400222
Authors:
Bradley A Warady
Pablo E Pergola
Rajiv Agarwal
Sharon Andreoli
Gerald B Appel
Sripal Bangalore
Geoffrey A Block
Arlene B Chapman
Melanie P Chin
Keisha L Gibson
Angie Goldsberry
Kazumoto Iijima
Lesley A Inker
Clifford E Kashtan
Bertrand Knebelmann
Laura H Mariani
Colin J Meyer
Kandai Nozu
Megan O'Grady
Michelle N Rheault
Arnold L Silva
Peter Stenvinkel
Roser Torra
Glenn M Chertow
Affiliated Authors:
Gerald B Appel
Author Keywords:
alport syndrome
bardoxolone methyl
ckd
Publication Type:
Article
Unique ID:
10.2215/cjn.02400222
PMID:
Publication Date:
Data Source:
PubMed

Record Created: